Galante Joseph C 4
4 · CUMBERLAND PHARMACEUTICALS INC · Filed Mar 18, 2025
Insider Transaction Report
Form 4
Galante Joseph C
Director
Transactions
- Award
Common Stock
2025-03-17$5.17/sh+1,000$5,170→ 61,856 total
Footnotes (1)
- [F1]Restricted stock award will vest 100% on March 17, 2026.